TETAE Endocrinology
Diabetes

Breakthroughs in Islet Cell Transplantation

Dr. Alisher Rustamov - Scientific Committee

Abstract

Modern islet cell encapsulation methods show promise for long-term glycemic control without systemic immunosuppression.

Methodology

The study included patients with labile type 1 diabetes. Islet cells were isolated and coated with a biocompatible hydrogel.

The results demonstrate the potential of this technology as a platform for future clinical protocols.

Results

HbA1c values improved and severe hypoglycemia episodes decreased.

Related articles